In the past 52-week period, shares of Quest Diagnostics Incorporated (NYSE:DGX) have moved within the range of $79.12 to $112.96. On the stock’s most recent trading day, the company’s shares ended the regular session at $94.80, which is 16.08% lower than its 52-week high.
Quest Diagnostics Incorporated (DGX) has demonstrated a 20-day simple moving average (SMA) of 2.23%, and a 50-day SMA of -5.15%. This public company’s current market capitalization stands at $12.99 billion.
Analyzing Consensus Estimates, Sales Revenue and Net Income
Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Quest Diagnostics Incorporated (DGX) is Hold.
When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Quest Diagnostics Incorporated (DGX) delivered a 0.39% surprise with its net revenue. Sales reached $1.93 billion during the three-month period, compared to the average analyst estimate of $1.92 billion.
Meanwhile, during the same quarter Quest Diagnostics Incorporated (DGX) delivered a 2.70% earnings surprise. Net earnings for the quarter were posted at $1.39 per share, whereas Wall Street had forecast $1.35 per share.
Ownership at Quest Diagnostics Incorporated (DGX), According to Most Recent SEC Filings
A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. Quest Diagnostics Incorporated (DGX) has 0.14 billion shares outstanding currently, 90.76% of which belong to institutional investors. Those institutional holdings amount to $11.66 billion.
Additionally, according to the most recent 13F filing from Quest Diagnostics Incorporated (DGX), there were 72 new positions totaling 735,760 shares of the company’s stock. There were 45 sold out positions, on the other hand, totaling 1,535,159 shares.
Short, Medium and Long Term Indicators
Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Quest Diagnostics Incorporated (DGX) has had a 20-day average volume of 1,503,935 shares, with an average of 40% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 1,266,246 shares, with an average of 25% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,062,283 shares with 67% of long-term indicators pointing to Sell.